Champions Oncologyincis A Technology Enabled Oncology Research Company That Focuses On Accelerating Cancer Drug Development Through Preclinical And Clinical Solutionsoriginally Founded As Champions Biotechnologyincin 2007The Company Rebranded In 2011 To Emphasize Its Commitment To Personalized Oncology Drug Development The Company Offers A Range Of Servicesincluding Preclinical Testing Platforms With Over 1 400 Patient Derived Xenograft Models For Drug Testingand Clinical Specialty Testing Such As High Complexity Flow Cytometry And Next Generation Sequencing For Biomarker Analysischampions Oncology Also Provides Proprietary Data Platformsincluding A Multi Omics Molecular Data Center That Integrates Extensive Molecular Dataand Saas Solutions That Deliver Analytics Tools For Drug Development Champions Oncology Collaborates With Global Pharmaceutical And Biotech Firms To Enhance Drug Development Efficiencythe Company Operates As A Contract Research Organizationfocusing On Both Service Based Revenue And Saas Subscriptionswhile Addressing Unmet Needs In Oncology Drug Development
